Siemens Healthineers expects FY2027 revenue growth of 4%-5%
Siemens Healthineers expects FY2027 revenue growth of 4%-5% Nov 5 - Medical technology company Siemens Healthineers SHLG.DE issued its fiscal 2027 outlook on Thursday after reporting fourth-quarter results as weakness in China continued to weigh on its diagnostics business.
The company expects fiscal 2027 comparable revenue growth of 4%-5% and adjusted basic earnings per share of 2.20 euros ($2.48) to 2.40 euros ($2.70).
Fourth-quarter adjusted EBIT fell 2.0% to 1.077 billion euros from 1.098 billion euros a year earlier
Fourth-quarter revenue rose 7.3% to 6.784 billion euros from 6.322 billion euros a year earlier
Fourth-quarter diagnostics revenue fell 4.2% on a comparable basis to 1.067 billion euros
Weakness in China remained a challenge, with diagnostics revenue in the region hurt by structural changes in the market environment
China accounts for about 10% of group revenue and is Siemens Healthineers' second-largest market after the US
The German company will change its name to Healthineers as part of its planned spin-off from Siemens, which shareholders are due to vote on in February 2027
($1 = 0.8880 euros)
(Reporting by Kira Britten and Paolo Laudani, editing by Matt Scuffham)
((Kira.Britten@thomsonreuters.com))
Recent news on Siemens Healthineers AG
See all newsSiemens Healthineers forecasts slower 2027 growth as China weakness persists (updated)
Siemens Healthineers seen sliding after 'not good enough' outlook
Siemens Healthineers begins carve-out of diagnostics unit amid China weakness (updated)
Brief: Siemens Healthineers - For FY 2027, Expect Comparable Revenue Growth Between 4.0% And 5.0% Over FY 2026
Siemens Healthineers starts Diagnostics carve-out, names unit Olyrian